AMPK activation is associated with inhibition of GSK3β (50), and JXGT-mediated activation of AMPK in our HFD-fed model also decreased the obesity-induced overexpression of GSK3β. Here, GSK3B is linked to obesity due to melanocortin 4 receptor deficiency.